American Chemistry Council
UnclaimedIndustry
Chemicals
Staff
75
HQ
700 2nd Street Northeast, Washington, DC
Phone
+1 202-249-7000
Website
americanchemistry.comEngagement overview
American Chemistry Council has filed 2,033 public comments across 1,040 dockets at 31 federal agencies, most actively at the Environmental Protection Agency.
2,033
Comments filed
1,040
Dockets engaged
31
Agencies
Jul 22, 2026
Last filing
Is this your organization?
Claim American Chemistry Council to unlock owner-only intelligence across your 1,040 dockets:
- Coalition map — every organization that files alongside you
- Ally & opposition tags on your co-filers
- AI briefs on the rulemakings you engage
- Deadline calendar & alerts for open comment windows
Agency footprint
Dockets · FDA (22)
sorted by most recent filingFDANonrulemakingFDA-2025-N-1793
Food Safety and Inspection Service Ultra-Processed Foods; Request for Information
1 of your filingslast filed Oct 10, 2025126 co-filers
FDANonrulemakingFDA-2025-N-1733
Tool for the Prioritization of Food Chemicals for Post-Market Assessment
1 of your filingslast filed Aug 19, 202532 co-filers
FDARulemakingFDA-2022-F-1108
Environmental Defense Fund, Maricel Maffini, Breast Cancer Prevention Partners, Clean Water Action/Clean Water Fund, Consumer Reports, Endocrine Society, Environmental Working Group, Healthy Babies Bright Futures, and the Nicholas School of the Environment at Duke University; Filing of Food Additive Petition
1 of your filingslast filed Sep 13, 20220 co-filers
FDANonrulemakingFDA-2021-P-0653
Requests that the FDA comply with the Federal Food and Drug Cosmetic Act (FFDCA) and its implementing regulations.
1 of your filingslast filed Jun 30, 20220 co-filers
FDANonrulemakingFDA-2021-P-0438
Request that the FDA enforce the Delaney Clause which prohibits the introduction of carcinogenic substances in the human food supply
1 of your filingslast filed Jun 30, 20220 co-filers
FDANonrulemakingFDA-2019-N-3793
General Hospital and Personal Use Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
1 of your filingslast filed Oct 24, 20191 co-filers
FDANonrulemakingFDA-2012-N-0143
Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List
2 of your filingslast filed Oct 7, 20199 co-filers
FDARulemakingFDA-2015-N-0101
Safety and Effectiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use
6 of your filingslast filed Apr 12, 201910 co-filers
FDARulemakingFDA-2016-N-0124
Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record
2 of your filingslast filed Dec 28, 20160 co-filers
FDANonrulemakingFDA-2013-D-1009
Use of Nanomaterials in Food for Animals
2 of your filingslast filed Aug 6, 20150 co-filers
FDANonrulemakingFDA-2015-N-0045
International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AH-7921; Gamma-Butyrolactone (GBL); 1,4-Butanediol; 9 Additional Substances; Request for Comments
2 of your filingslast filed Feb 27, 201562 co-filers
FDANonrulemakingFDA-2013-D-1039
Endocrine Disruption Potential of Drugs: Nonclinical Evaluation
1 of your filingslast filed Jun 27, 20140 co-filers
FDARulemakingFDA-2011-N-0921
Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption
1 of your filingslast filed Apr 15, 2014172 co-filers
FDARulemakingFDA-2011-N-0920
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls For Human Food
1 of your filingslast filed Feb 3, 2014223 co-filers
FDANonrulemakingFDA-2013-N-0222
International Conference on Harmonisation; Proposed Change to Rodent Carcinogenicity Testing of Pharmaceuticals; Request for Comments
1 of your filingslast filed May 21, 20130 co-filers
FDANonrulemakingFDA-2011-D-0489
Safety of Nanomaterials in Cosmetic Products
1 of your filingslast filed Aug 7, 20120 co-filers
FDANonrulemakingFDA-2011-D-0490
Draft Guidance for Industry: Assessing the Effects of Significant Manufacturing Process Changes, Including Emerging Technologies, on the Safety and Regulatory Status of Food Ingredients and Food Contact Substances, Including Food Ingredients that are Color Additives; Availability
1 of your filingslast filed Aug 7, 20120 co-filers
FDANonrulemakingFDA-2012-D-0108
Draft Guidance for Industry on Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products
1 of your filingslast filed Jun 13, 20120 co-filers
FDANonrulemakingFDA-1993-N-0259
Quality Standard for Foods With No Identity Standards; Bottled Water
1 of your filingslast filed Jun 3, 20100 co-filers
FDANonrulemakingFDA-2006-N-0100
FDA-Regulated Products Containing Nanotechnology Materials
2 of your filingslast filed Apr 4, 20090 co-filers
FDANonrulemakingFDA-2008-N-0416
Consideration of FDA-Regulated Products that May Contain Nanoscale Materials; Public Meeting and Data Call
1 of your filingslast filed Oct 29, 20081 co-filers
FDANonrulemakingFDA-2008-N-0448
International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Gamma-hydroxybutyric acid (GHB); Ketamine; Dextromethorphan; N-benzylpiperazine (BZP); 1-(3-trifluoromethylphenyl)piperazine (TFMPP); 1-(3-chlorophenyl)piperazine (mCPP); 1-(4-Methoxyphenyl)piperazine (MeOPP); 1-(3,4-methylenedioxybenzyl)piperazine (MDBP); Gamma-butyrolactone; 1,4-Butanediol
1 of your filingslast filed Oct 3, 20082 co-filers
Attribution is name-based and imperfect. Firmographic data is third-party sourced and shown for demonstration. regulations.gov data is public record.